Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Vitro Diagnostics (VODG) had Revenue of $0.49M for the most recently reported fiscal quarter, ending 2025-10-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-10-31

Income Statement Financials
Revenue	$0.49M
Net Income	$-4.85M
Cost of Goods Sold	$0.19M
Gross Profit	$0.30M
Operating Expenses	$1.69M
Operating Income	$-1.21M
Non-Operating Income/Expense	$-3.63M
Pre-Tax Income	$-4.84M
Normalized Pre-Tax Income	$-4.84M
Income after Taxes	$-4.84M
Income from Continuous Operations	$-4.84M
Consolidated Net Income/Loss	$-4.84M
Normalized Income after Taxes	$-4.84M
EBIT	$-1.21M
EBITDA	$0.40M
Weighted-Average Shares Outstanding (Basic)	4.46M
Weighted-Average Shares Outstanding (Diluted)	4.46M
Earnings per Share (EPS) (Basic)	$-1.09
Earnings per Share (EPS) (Diluted)	$-1.09
Balance Sheet Financials
Current Assets	$0.86M
Property, Plant, and Equipment	$0.04M
Long-Term Assets	$4.07M
Total Assets	$4.93M
Current Liabilities	$5.68M
Long-Term Debt	$8.99M
Long-Term Liabilities	$15.58M
Total Liabilities	$21.26M
Common Equity	$-16.33M
Tangible Shareholders Equity	$-19.99M
Shareholders Equity	$-16.33M
Common Shares Outstanding	4.46M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.54M
Cash Flow from Investing Activities	$-0.07M
Cash Flow from Financial Activities	$2.64M
Beginning Cash	$0.57M
End Cash	$0.60M
Increase/Decrease in Cash	$0.03M
Stock-Based Compensation	$1.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.15
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-1.22
Debt to Equity Ratio	-0.59
Gross Margin	61.82%
Operating Margin	-247.61%
EBIT Margin	-247.61%
EBITDA Margin	--
Pre-Tax Profit Margin	-994.38%
Profit Margin	-996.95%
Free Cash Flow	$-2.54M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	1.38
Receiveable Turnover	5.88
Days Sales in Receivables	15.31
Return on Equity	29.63%
Return on Tangible Equity	24.21%
Return on Assets	-98.19%
Return on Investments	65.92%
Book Value Per Share	$-3.66
Free Cash Flow per Share	$-0.57
Operating Cash Flow per Share	$-0.57

Data from Zacks Investment Research, Inc.